miR-194 Original DATA.xls
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接:
https://figshare.com/articles/dataset/miR-194_Original_DATA_xls/6364451
下载链接
链接失效反馈官方服务:
资源简介:
Hypothermia has been
reported to be effective in protecting the brain in various clinical
conditions, including resuscitation after cardiac arrest and complex
cardiovascular surgery, and is considered to be a promising therapy for stroke. The present study aimed to confirm a
pivotal role for miRNA-194-5p in
deep hypothermia circulation arrest. We
observed a decline in expression of miR-194-5p in the circulation of 21 aortic
dissection patients who underwent deep hypothermia circulatory arrest.
Subsequently, the specific expression, target, and function of miR-194-5p was
investigated using primary neuron culture, polymerase chain reaction, in situ
hybridization, and flow cytometry methods. Our results showed that miR-194-5p
expression was significantly downregulated in neurons subjected to hypothermia and
oxygen-glucose deprivation in
vitro. Cortical neurons transfected with
miR-194-5p mimic exhibited increased death due to oxygen-glucose deprivation.
MiR-194-5p mediated the regulation of neuronal death, which involves the
downregulation of the specific target protein SUMO2, which is a crucial protein
in ischemia tolerance. Collectively, these data highlight the unique role of
miR-194-5p in mediating the deep hypothermia circulation arrest response via the regulation of SUMO2. These
findings suggest that miR-194-5p could be a potential therapeutic target for
intervention in ischemic disease.
已有研究表明,低体温疗法在多种临床场景中可发挥脑保护作用,涵盖心搏骤停后复苏以及复杂心血管手术领域,且被视为脑卒中治疗的极具潜力的方案。本研究旨在明确微小RNA-194-5p(miRNA-194-5p)在深低温停循环中的关键作用。我们在21例接受深低温停循环手术的主动脉夹层患者的循环样本中,观测到miR-194-5p的表达水平显著下降。随后,我们通过原代神经元培养、聚合酶链式反应、原位杂交以及流式细胞术等实验手段,对miR-194-5p的特异性表达、靶标及功能展开研究。体外实验结果显示,在经低体温处理及氧糖剥夺的神经元中,miR-194-5p的表达水平显著下调。转染miR-194-5p模拟物的皮质神经元,在氧糖剥夺条件下的细胞死亡率显著升高。miR-194-5p可介导神经元死亡的调控过程,其机制涉及下调特异性靶标蛋白小泛素样修饰蛋白2(SUMO2)——该蛋白是缺血耐受中的关键分子。综上,本研究数据表明,miR-194-5p可通过调控SUMO2的表达,在深低温停循环应答过程中发挥独特作用。本研究结果提示,miR-194-5p或可成为缺血性疾病干预的潜在治疗靶点。
创建时间:
2018-05-26



